Neoleukin Therapeutics Inc (OQ:NLTX)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for NLTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 17th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 11/19 Sep 11/19 Drachman Jonathan G Direct Ownership Common Stock P - Open market or private purchase 136,436 $3.30
Sep 11/19 Sep 10/19 Drachman Jonathan G Direct Ownership Common Stock P - Open market or private purchase 36,742 $3.08
Sep 11/19 Sep 9/19 Drachman Jonathan G Direct Ownership Common Stock P - Open market or private purchase 76,822 $2.85
Sep 4/19 Aug 31/19 Drachman Jonathan G Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 1,650,000  
Aug 12/19 Aug 8/19 Drachman Jonathan G Direct Ownership Series A Preferred Stock A - Grant, award or other under Rule 16b-3(d) 7,428  
Aug 12/19 Aug 8/19 Drachman Jonathan G Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 334,428  
Sep 13/19 Aug 8/19 Drachman Jonathan G Direct Ownership Series A Preferred Stock A - Grant, award or other under Rule 16b-3(d) 12,616  
Sep 13/19 Aug 8/19 Drachman Jonathan G Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 568,039  
Aug 8/19 Aug 7/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock P - Open market or private purchase 4,564 $3.15
Aug 8/19 Aug 7/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock P - Open market or private purchase 209,382 $3.02
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for NLTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 17th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 13/19 Aug 8/19 Drachman Jonathan G Direct Ownership Series A Preferred Stock A - Grant, award or other under Rule 16b-3(d) 12,616  
Sep 13/19 Aug 8/19 Drachman Jonathan G Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 568,039  
Sep 11/19 Sep 11/19 Drachman Jonathan G Direct Ownership Common Stock P - Open market or private purchase 136,436 $3.30
Sep 11/19 Sep 10/19 Drachman Jonathan G Direct Ownership Common Stock P - Open market or private purchase 36,742 $3.08
Sep 11/19 Sep 9/19 Drachman Jonathan G Direct Ownership Common Stock P - Open market or private purchase 76,822 $2.85
Sep 4/19 Aug 31/19 Drachman Jonathan G Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 1,650,000  
Aug 12/19 Aug 8/19 Drachman Jonathan G Direct Ownership Series A Preferred Stock A - Grant, award or other under Rule 16b-3(d) 7,428  
Aug 12/19 Aug 8/19 Drachman Jonathan G Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 334,428  
Aug 8/19 Aug 7/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock P - Open market or private purchase 4,564 $3.15
Aug 8/19 Aug 7/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock P - Open market or private purchase 209,382 $3.02
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $NLTX

StockTwits